Over the last 7 days, the Pharma industry has remained flat, although notably Y.S.P. Southeast Asia Holding Berhad gained 16%. As for the longer term, the industry has declined 3.2% in the last year. In the next few years, earnings are forecast to decline by 16% annually.
Has the Malaysian Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Tue, 28 May 2024 | RM4.5b | RM2.6b | RM541.4m | 13.3x | 8.4x | 1.7x |
Thu, 25 Apr 2024 | RM4.6b | RM2.6b | RM559.3m | 12.3x | 8.3x | 1.8x |
Sat, 23 Mar 2024 | RM4.6b | RM2.6b | RM559.3m | 12.3x | 8.2x | 1.7x |
Mon, 19 Feb 2024 | RM4.7b | RM2.6b | RM584.9m | 12.3x | 8x | 1.8x |
Wed, 17 Jan 2024 | RM4.3b | RM2.6b | RM584.9m | 12.3x | 7.4x | 1.7x |
Fri, 15 Dec 2023 | RM4.1b | RM2.6b | RM584.9m | 12.2x | 7.1x | 1.6x |
Sun, 12 Nov 2023 | RM4.2b | RM2.6b | RM597.0m | 12.1x | 7.1x | 1.6x |
Tue, 10 Oct 2023 | RM4.3b | RM2.6b | RM604.4m | 12.4x | 7.1x | 1.7x |
Thu, 07 Sep 2023 | RM4.3b | RM2.6b | RM604.4m | 12.5x | 7.1x | 1.7x |
Sat, 05 Aug 2023 | RM4.4b | RM2.6b | RM304.7m | 14x | 14.5x | 1.7x |
Mon, 03 Jul 2023 | RM4.2b | RM2.6b | RM304.7m | 14.1x | 13.9x | 1.7x |
Wed, 31 May 2023 | RM4.6b | RM2.6b | RM305.1m | 13.5x | 15.1x | 1.8x |
Fri, 28 Apr 2023 | RM4.7b | RM2.5b | RM289.8m | 13.1x | 16.1x | 1.9x |
Sun, 26 Mar 2023 | RM4.7b | RM2.5b | RM289.8m | 13.1x | 16.3x | 1.9x |
Tue, 21 Feb 2023 | RM4.7b | RM2.4b | RM270.7m | 13.6x | 17.5x | 1.9x |
Thu, 19 Jan 2023 | RM4.6b | RM2.4b | RM270.7m | 12.8x | 17.1x | 1.9x |
Sat, 17 Dec 2022 | RM4.6b | RM2.4b | RM270.7m | 13.3x | 17.1x | 1.9x |
Mon, 14 Nov 2022 | RM4.2b | RM2.4b | RM248.4m | 12.5x | 16.8x | 1.7x |
Wed, 12 Oct 2022 | RM3.8b | RM2.4b | RM249.0m | 11.3x | 15.4x | 1.6x |
Fri, 09 Sep 2022 | RM3.9b | RM2.4b | RM249.0m | 11.8x | 15.5x | 1.6x |
Sun, 07 Aug 2022 | RM3.9b | RM2.3b | RM226.0m | 13.9x | 17.1x | 1.7x |
Tue, 05 Jul 2022 | RM3.5b | RM2.3b | RM226.0m | 13.6x | 15.6x | 1.5x |
Thu, 02 Jun 2022 | RM3.8b | RM2.3b | RM226.0m | 14.2x | 17x | 1.7x |
Sat, 30 Apr 2022 | RM4.0b | RM2.2b | RM204.5m | 16.8x | 19.6x | 1.8x |
Mon, 28 Mar 2022 | RM3.9b | RM2.2b | RM204.5m | 16.2x | 18.9x | 1.7x |
Wed, 23 Feb 2022 | RM3.7b | RM2.2b | RM186.9m | 16.4x | 20x | 1.7x |
Fri, 21 Jan 2022 | RM3.6b | RM2.1b | RM187.4m | 15.3x | 19.3x | 1.7x |
Sun, 19 Dec 2021 | RM3.6b | RM2.1b | RM187.4m | 15.1x | 19.4x | 1.7x |
Tue, 16 Nov 2021 | RM3.8b | RM2.0b | RM166.6m | 21x | 22.7x | 1.9x |
Thu, 14 Oct 2021 | RM3.9b | RM2.0b | RM166.6m | 21x | 23.2x | 1.9x |
Sat, 11 Sep 2021 | RM4.1b | RM2.0b | RM166.5m | 21.2x | 24.8x | 2.1x |
Mon, 09 Aug 2021 | RM4.0b | RM2.0b | RM166.5m | 19.6x | 23.9x | 2x |
27.4x
How does Malaysian Pharma compare with similar industries?
MY Market | -0.46% | |
Healthcare | -2.94% | |
Pharma | -2.08% | |
Pharma | -2.08% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
YSPSAH Y.S.P. Southeast Asia Holding Berhad | RM2.98 | 14.6% +RM53.9m | 18.3% | PE10.5x | |
PLABS PeterLabs Holdings Berhad | RM0.21 | 2.4% +RM1.4m | 13.5% | PE16.8x |